Before choosing Immortals, ask for an explanation of the specific offer you would actually receive—not just the medication name or monthly headline. Its product pages combine physician review, medication choices, member discounts and quarterly payment conditions. Those elements do not necessarily describe one all-inclusive plan. The most useful preparation is to establish which product is proposed, who would prescribe and dispense it, what the first charge covers, and how help works after delivery.
This documentary review examines public pages consulted October 19, 2026. Immortals describes a telehealth platform connecting adults with physicians for treatment when appropriate; prescriptions are not guaranteed. It advertises compounded semaglutide and tirzepatide alongside branded products, with a separate biomarker-testing subscription and a broader longevity app offering. The central question is not whether the website has a wide menu. It is whether the company can turn that menu into a clear, individualized explanation of treatment, cost and ongoing responsibility before you pay.
At a glance
- Access and approval
- Immortals Medicine serves adults 18 and older in eligible U.S. states; a physician reviews each case, and prescriptions are not guaranteed.Sources: [8]
- Compounded products
- The platform advertises weekly injectable compounded tirzepatide and semaglutide with glycine and B12, and acknowledges that compounded formulations are not FDA approved.
- Discount conditions
- Displayed member prices include $217 per month for compounded tirzepatide and $167 per month for compounded semaglutide, each billed quarterly with a three-month commitment paid upfront. Membership cost is not established.
- Cancellation and refunds
- General subscription terms require cancellation at least 24 hours before the period ends to avoid the next charge. The medicine policy says sales are final, without returns or refunds.
- Separate laboratory subscription
- Biomarker Tests costs $365 per year for two rounds of blood and urine testing plus platform access, with specific state exclusions.Sources: [13]
Start by separating the company, clinician and pharmacy
Immortals operates within a larger longevity business. Its terms identify Continuance LLC and subsidiaries as the operator of services under Immortals, Blueprint, Don’t Die and Bryan Johnson brands. The homepage attributes the founding of Immortals and Blueprint to Bryan Johnson and Kate Tolo. That background explains the platform’s positioning, but it does not identify the medical practice responsible for a particular patient’s prescription or the pharmacy responsible for filling it.
Immortals Medicine says it connects patients with licensed physicians. A product page describes review by a U.S.-licensed, board-certified physician, while the homepage presents Carl Seger, M.D., as a board-certified physician specializing in preventive and longevity medicine. These are provider statements, not independently verified credentials. The consulted documentation does not name the dispensing pharmacies or clearly establish the clinical entity responsible for consultations and prescriptions.
Ask for the prescribing practice’s name, your clinician’s role and the dispensing pharmacy’s contact information before purchasing. Also establish which organization handles medical questions, billing disputes and prescription errors. A recognizable consumer brand does not by itself answer those operational questions. Our guide to what a program should explain before enrollment offers a useful framework for organizing the answers without treating marketing familiarity as verification.
Ask which medicine and presentation the offer actually covers
The compounded menu includes tirzepatide with glycine and B12 and semaglutide with glycine and B12, each described as a weekly injectable. The tirzepatide page also lists personalized-dose and microdose choices. These labels identify advertised options, not evidence that a particular option is appropriate for you. Ask which formulation, presentation and quantity would be prescribed, and whether the price shown corresponds to that exact selection.
The branded listings require their own questions. The Wegovy page identifies semaglutide and displays both tablets and injections, but the consulted text does not establish which presentation matches its displayed price. Zepbound KwikPen is presented as a weekly tirzepatide injection. Immortals identifies Foundayo as orforglipron in a daily oral tablet. These are descriptions of the provider’s listings; the review does not independently verify every advertised presentation or its availability.
Immortals acknowledges that its compounded formulations are not FDA approved. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence, but neither do ingredient names establish equivalent results. Before comparing offers, use these questions about the exact medicine to distinguish branded products, compounded blends, routes and supply quantities.
Request a complete first-charge and renewal quote
Immortals says prices vary by medication and dose, that insurance is not required, and that patients are charged only after physician approval. Its product pages also say membership fees are not required to access treatment. However, the lower displayed totals are member prices. The consulted documentation does not establish the membership fee or its complete conditions, so those lower figures cannot be treated as the total cost of joining and receiving medication.
Every member total in the table carries the same footnote: quarterly billing with a three-month commitment paid upfront. These are monthly price expressions, not evidence of cancellable month-to-month payment. The displayed subtotals are separate figures; their complete billing arrangements need confirmation. Wegovy’s price also remains unresolved by presentation. Obtain an itemized quote identifying the selected medicine, dose, supply, membership charge, collection schedule and any applicable taxes or transaction fees.
The pages repeatedly advertise potential annual savings of $459 despite showing different monthly discounts. The documentation does not reconcile that claim across products, so it is not a reliable personalized savings estimate. Nor is it clear whether video visits, injection supplies, shipping or necessary laboratory work are included in each price. Bring a checklist of questions beyond the monthly headline, and ask for answers in writing before authorizing payment.
| Advertised product | Displayed subtotal | Displayed member total and presentation limitation |
|---|---|---|
| Compounded tirzepatide with glycine and B12, weekly injectable | $255/month | $217/month; exact selected option and supply need confirmation |
| Compounded semaglutide with glycine and B12, weekly injectable | $196/month | $167/month; exact selected option and supply need confirmation |
| Wegovy, identified as semaglutide | $1,550/month | $1,317/month; price cannot be assigned clearly to tablets versus injections |
| Zepbound KwikPen, tirzepatide injection | $600/month | $510/month; exact supply needs confirmation |
| Foundayo, identified as orforglipron oral tablets | $750/month | $637/month; exact supply needs confirmation |
Prepare for the consultation, not just the intake form
Immortals describes its initial intake as taking five to ten minutes. The guided questions cover medical history, current medications, goals and treatment preferences, and a physician reviews each case before a prescription is issued. Some states may require a synchronous audio or video consultation. Ask whether your own review will involve a live conversation, how you can raise concerns before approval, and whether any additional consultation carries a separate fee.
The eligibility statement is adults 18 and older in eligible U.S. states, with some medications unavailable in certain states. Although the general terms list services across all 50 states, that does not establish access to every medication everywhere. The documentation does not provide a medication-by-state map or the service’s clinical BMI thresholds. The Personalized Tirzepatide listing says it is not recommended for people with a personal or family history of medullary thyroid cancer or MEN2, and that the physician will evaluate whether treatment is appropriate. Confirm your state and proposed product together rather than relying on the general geographic statement.
Review timing is not uniform across the pages: the collection says physician review is typically completed within 24 hours, while product pages say within 72 hours. Neither statement guarantees approval. NIDDK advises discussing current medicines, supplements, allergies and pregnancy plans with a clinician, alongside benefits, side effects and cost. Prepare that information, then ask what further evaluation is needed rather than treating a short intake as a complete clinical assessment.
Clarify what happens between prescription and delivery
Immortals advertises direct delivery in discreet packaging. The collection says most medications ship within two to five business days after review and prescribing, while product pages also display a two-to-five-business-day shipping statement. A separate headline describes three to seven days from intake to the door. These are different milestones. Ask which estimate applies to your order and distinguish prescription review, pharmacy dispatch and actual arrival.
The consulted documentation does not establish the carrier, tracking arrangements, refrigeration requirements or procedures for delayed, damaged or missing packages. It also does not identify the dispensing pharmacy by name. Before shipment, request the pharmacy’s direct contact details, the expected presentation and storage instructions, and a clear route for reporting delivery problems. An advertised delivery window does not resolve who bears responsibility when a package is unusable or never arrives.
FDA specifically advises not using an injectable GLP-1 product that arrives warm or with insufficient refrigeration, and contacting the provider or dispensing pharmacy. That guidance matters independently of Immortals’ advertised delivery speed. Ask how the company documents and resolves a temperature concern, including whether a replacement is considered and who evaluates the shipment. The medicine policy’s invitation to report filling errors does not itself establish a complete delivery-remediation policy.
Find out what unlimited messaging means in practice
The product page advertises unlimited physician messaging, says the doctor is available through chat for additional support, and notes that video consultations are available. The support description includes a period of up to 12 months. It does not establish a response deadline, emergency coverage or whether every video visit is included in medication pricing. Ask when that support period begins, what maintains access, and who answers when the prescribing physician is unavailable.
Follow-up should be distinguishable from simply renewing a payment. NIDDK describes ongoing care in terms of response and tolerance, with treatment duration depending on benefits and side effects. Ask Immortals how follow-up is scheduled, how concerns reach the prescriber, and what happens if a clinician decides the current treatment should not continue. Unlimited messages are a useful access feature only when the responsibilities and response expectations are understandable.
The longevity framing also deserves careful interpretation. Immortals markets personalized formulations and possible benefits from added ingredients, but the consulted documentation does not establish clinical outcomes for its particular compounded blends or microdose options. The STEP 1 and SURMOUNT-1 trials were not trials of Immortals or its compounded products. Ask what evidence supports the exact proposed formulation and distinguish that answer from broader research on a medication ingredient.
Keep biomarker testing and app access separate from medication care
Immortals’ separate Biomarker Tests subscription is advertised at $365 annually. Its stated inclusions are two comprehensive blood panels and urine tests per year, more than 100 unique biomarkers, at least 160 measurements, and access to the Biomarkers platform. Initial and follow-up appointments are scheduled through that platform at a local Quest Diagnostics laboratory. These inclusions do not establish that the subscription is required for GLP-1 treatment or included in medication prices.
Testing has its own geography: customers must be at least 18 and based in the United States, with Arizona, Hawaii, New Jersey, New York and Rhode Island currently excluded. Results timing is presented inconsistently: a headline says a week, while the FAQ says 95% receive complete results within two weeks. Ask which tests are actually needed for your care and whether existing results can be used before purchasing a separate subscription.
The homepage calls the app and uploading outside biomarker results free, with prescriptions, panels and supplements optional. However, it also includes a coming-soon notice, leaving actual app availability unclear. The terms state that AI tools do not provide medical advice and may be inaccurate. Biomarker HSA/FSA documentation also depends on eligibility review; receiving a letter of medical necessity is not the same as confirmed reimbursement from your account administrator.
Resolve the exit process before the next charge
The general subscription terms say plans automatically renew until terminated. Cancellation must occur at least 24 hours before the current period ends to avoid the next billing cycle. Account settings provide the stated cancellation route, and cancellation takes effect at the end of the current period, removing future charges rather than reversing existing ones. Confirm exactly how those general rules apply to your medication purchase, membership and any separate testing subscription.
The medicine-specific policy says all sales are final, with no refunds or returns. It invites contact if you believe an error occurred in filling the prescription. General terms also contemplate legal exceptions and discretionary refunds, but those provisions do not create a promised refund for changing your mind or canceling. Ask what happens if treatment becomes unsuitable during a prepaid period, and request the applicable written policy rather than assuming unused treatment is refundable.
It remains unclear how prescription renewal, clinical reassessment and subscription renewal interact for each medication plan. Before enrolling, identify the next charge date, cancellation deadline, future review requirements and any separate membership renewal. Save the terms attached to the actual offer. These questions to settle before renewal can help distinguish ending a financial subscription from arranging an appropriate clinical follow-up plan with your treating professional.
Questions & answers
Do I have to buy an Immortals membership to receive treatment?
The product page says membership fees are not required to access treatment. However, its discounted totals are specifically member prices, and the consulted documentation does not establish the membership fee or full conditions. Ask for both a nonmember quote and a member quote, including every charge. Do not assume that the membership discount is available without a separate membership purchase or that its fee is already included.
Is the advertised $217 tirzepatide price a monthly payment plan?
The $217-per-month member total is advertised with quarterly billing and a three-month commitment paid upfront. It applies to a listing for compounded tirzepatide with glycine and B12, described as a weekly injectable. It should not be read as an independently cancellable monthly payment. Confirm the exact selected option, supply quantity, membership charge and collected amount; the displayed $255 monthly subtotal has separate billing details that also need clarification.
Does Immortals accept insurance for GLP-1 treatment?
Immortals says insurance is not required. That does not establish whether it accepts insurance, submits medication claims, handles prior authorization or offers a covered consultation. The consulted documentation does not resolve those questions. Ask the company about its billing process and your health plan about coverage for the exact product and presentation. The separate biomarker HSA/FSA eligibility process is not evidence of medication insurance coverage.
Can I use Immortals from any U.S. state?
The general terms list all 50 states, but Immortals Medicine limits access to adults in eligible states and says some medications are unavailable in certain states. Confirm the specific medication in your state before proceeding. Biomarker Tests has a different rule: it excludes Arizona, Hawaii, New Jersey, New York and Rhode Island. General platform availability should not be substituted for either medication-specific or laboratory-specific availability.
How quickly should I expect a prescription and delivery?
The collection says review typically takes 24 hours, whereas product pages say within 72 hours. Most medications are advertised as shipping two to five business days after review and prescribing; another headline gives three to seven days from intake to the door. These are not interchangeable guarantees. Approval is not assured, dispatch is not arrival, and the documentation does not establish a detailed delay or lost-package procedure.
Will canceling Immortals return money already paid?
Do not assume so. The medicine policy states that sales are final without refunds or returns. General subscription cancellation stops future charges and takes effect at the end of the current period; it requires at least 24 hours’ notice before the period ends to avoid the next charge. Ask how these rules apply to your exact prepaid medication arrangement and how a suspected prescription-filling error would be investigated.
Our assessment
Immortals documents a substantial medication menu, physician review before prescribing, advertised messaging support and visible product prices. Those are useful starting points for comparing care. Its main unresolved issues are equally practical: the total membership-inclusive cost, exact supply behind each price, named clinical and pharmacy responsibilities, included services and the handling of delivery problems. The strongest next step is an itemized written offer paired with a clear clinical contact and cancellation explanation. Its longevity branding and broader testing ecosystem do not answer those questions, and published drug trials do not establish outcomes for this platform’s compounded blends. Evaluate the specific care arrangement rather than the breadth of the storefront.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Immortals — collections/weight loss prescriptions/products/foundayo ↗
- Immortals — collections/weight loss prescriptions/products/zepbound kwikpen ↗
- Immortals — collections/weight loss prescriptions/products/wegovy ↗
- Immortals — collections/weight loss prescriptions ↗
- Immortals — collections/weight loss prescriptions/products/tirzepatide ↗
- Immortals — policies/refund policy ↗
- Immortals — policies/terms of service ↗
- Immortals — collections/weight loss prescriptions/products/semaglutide ↗
- Immortals — pages/biomarkers ↗
- Immortals — official website ↗